Drugs to treat multi resistant TB is not easily accessible

By  ,  Onlymyhealth editorial team
Jan 20, 2017

Despite the fact that Bedaquiline - a medicine used to treat Multidrug-Resistant Tuberculosis (MTR TB) - hurriedly introduced last year with the motive of making India TB-free, it continues to be in trial and is still available only in six centres in the country.





According to the World Health Organization report of 2015, 10.4 million contracted tuberculosis and 1.8 million died from the disease. These alarming statistics coupled with the rise of multi-drug resistant tuberculosis are concerning health professionals. Health authorities are highly concerned of the extensively drug-resistant tuberculosis because of the way tuberculosis spreads.


In the latest update regarding tuberculosis, scientists have found success in clinical trials for a possible new vaccine against multi-drug resistant tuberculosis.


A new study found that strains of tuberculosis that bypass most of the drugs that are usually used to treat bacterial infection have been spreading in South Africa, which already has a high tuberculosis infection rate.


Though the efforts of doctors and scientists in working towards eradicating the disease are being applauded, the need for a more accessible scheme that would provide those, especially in the rural population, with sustainable treatment is felt urgent by the public.


Image Source: Getty

Read More : Health News

Is it Helpful Article?YES1 Vote 781 Views 0 Comment
I have read the Privacy Policy and the Terms and Conditions. I provide my consent for my data to be processed for the purposes as described and receive communications for service related information.
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK